PALB2 and neoplasm: As shown in Fig. 4b, the percent of germline LP/P variants within the traditional genetic counseling and tumor DNA safety net groups was similar for BRCA2 (40% versus 32%), PALB2 (3% versus 8%), and Lynch syndrome genes (collectively 19% versus 13%).